Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer

W J Ellis1, P H Lange

  • 1Department of Urology, University of Washington, Seattle.

Endocrinology and Metabolism Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Prostate cancer is a significant health concern, especially in aging men. New diagnostic and therapeutic strategies are urgently needed as current treatments are largely ineffective against this disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.

Prostate cancer and prostatic diseases·2016
Same author

Experimental models and methods in antibody targeting of renal cell carcinoma.

Methods in molecular medicine·2011
Same author

Acceptability of an Internet treatment decision support program for men with prostate cancer.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2006
Same author

A novel monoclonal antibody 107-1A4 with high prostate specificity: generation, characterization of antigen expression, and targeting of human prostate cancer xenografts.

Prostate cancer and prostatic diseases·2002
Same author

Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy.

BJU international·2001
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Urology
  • Geriatric Medicine

Background:

  • Prostate carcinoma presents a growing health challenge in aging populations.
  • It is the second leading cause of cancer-related mortality in males.
  • Current prostate cancer screening methods are controversial and lack definitive proof of efficacy.

Purpose of the Study:

  • To highlight the urgent need for novel diagnostic and therapeutic strategies in prostate cancer management.
  • To address the limitations of current prostate cancer screening and treatment protocols.
  • To emphasize the necessity for improved biologic assessment and treatment modalities.

Main Methods:

  • This study is a review and analysis of current prostate cancer research and clinical practices.
  • It synthesizes existing data on screening efficacy, disease progression, and therapeutic outcomes.

Related Experiment Videos

  • Focuses on identifying gaps in knowledge and clinical application.

    • Main Results:

    • Prostate cancer often follows an indolent course but remains a leading cause of male cancer deaths.
    • Conventional chemotherapy demonstrates limited efficacy against prostate tumors.
    • Existing screening protocols are unproven and debated within the medical community.

    Conclusions:

    • Novel strategies for diagnosis and biologic assessment are critical for effective prostate cancer management.
    • The development of new therapeutic approaches is essential to overcome treatment resistance.
    • Containment of prostate cancer requires a multi-faceted approach integrating advanced diagnostics and innovative therapies.